Racivir

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Racivir
Accession Number
DB12753
Type
Small Molecule
Groups
Investigational
Description

Racivir, also known as RCV, is an oxothiolane nucleoside reverse transcriptase inhibitor similar to emtricitabine and lamivudine. Racivir is a 50:50 mixture of emtricitabine Emtricitabine and its positive enantiomer. Racivir has been used in trials studying the prevention of HIV Infections.

Synonyms
  • (+/-)-Emtricitabine
  • RCV
External IDs
PSI-5004
Categories
UNII
ULS8902U4O
CAS number
143491-54-7
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
Adenovirus type 7 vaccine liveThe therapeutic efficacy of Racivir can be decreased when used in combination with Adenovirus type 7 vaccine live.
Anthrax vaccineThe therapeutic efficacy of Racivir can be decreased when used in combination with Anthrax vaccine.
Bacillus calmette-guerin substrain connaught live antigenThe therapeutic efficacy of Racivir can be decreased when used in combination with Bacillus calmette-guerin substrain connaught live antigen.
Bacillus calmette-guerin substrain danish 1331 live antigenThe therapeutic efficacy of Racivir can be decreased when used in combination with Bacillus calmette-guerin substrain danish 1331 live antigen.
Bacillus calmette-guerin substrain tice live antigenThe therapeutic efficacy of Racivir can be decreased when used in combination with Bacillus calmette-guerin substrain tice live antigen.
BCG vaccineThe therapeutic efficacy of Racivir can be decreased when used in combination with BCG vaccine.
Human adenovirus e serotype 4 strain cl-68578 antigenThe therapeutic efficacy of Racivir can be decreased when used in combination with Human adenovirus e serotype 4 strain cl-68578 antigen.
Rubella virus vaccineThe therapeutic efficacy of Racivir can be decreased when used in combination with Rubella virus vaccine.
Typhoid Vaccine Live Ty21aThe therapeutic efficacy of Racivir can be decreased when used in combination with Typhoid Vaccine Live Ty21a.
Varicella Zoster Vaccine (Live/Attenuated)The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Racivir.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911373
Wikipedia
Racivir

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionHuman Immunodeficiency Virus (HIV) Infections1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on October 20, 2016 18:01 / Updated on June 04, 2019 07:42